← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
101	101 Genprex GNPX $1.88M	20	-1	-5%	$6.33M
102	102 Enlivex Ltd ENLV $4.46M	18	-4	-18%	$1.41M
103	103 ProKidney PROK $305M	18	-49	-73%	$144M
104	104 Creative Medical Technology CELZ $6.21M	17	+3	+21%	$258K
105	105 IN8bio INAB $11.7M	17	+2	+13%	$2.42M
106	KRBP 106 DELISTED Kiromic BioPharma, Inc. Common Stock KRBP	16	-1	-6%	$90.3K
107	LGVN 107 Longeveron LGVN $4.78M	16	+3	+23%	$1.64M
108	SCPS 108 DELISTED Scopus BioPharma Inc. Common Stock SCPS	15	-2	-12%	$111K
109	109 BioRestorative Therapies BRTX $2.02M	14	+2	+17%	$1.16M
110	FRLN 110 DELISTED Freeline Therapeutics Holdings plc American Depositary Shares FRLN	14	-3	-18%	$26.4M
111	111 Immix Biopharma IMMX $720M	12	+5	+71%	$406K
112	112 MiNK Therapeutics INKT $50.7M	11	0	0%	$1M
113	CYAD 113 DELISTED Celyad Oncology SA American Depositary Shares CYAD	8	0	0%	$9.07M
114	114 NewcelX Ltd NCEL $16.5M	4	0	0%	$72K
115	TCBP 115 DELISTED TC BioPharm (Holdings) plc American Depositary Shares TCBP	3	0	0%	$141K
116	116 Genenta Science GNTA $32.3M	2	-1	-33%	$17K
117	117 Artiva Biotherapeutics ARTV $296M	–	–	–	–
118	118 Coya Therapeutics COYA $102M	–	–	–	–
119	119 DELISTED CARGO Therapeutics CRGX	–	–	–	–
120	120 enGene Therapeutics ENGN $115M	–	–	–	–
121	121 FibroBiologics FBLG $7.08M	–	–	–	–
122	122 CytoMed Therapeutics GDTC $10.4M	–	–	–	–
123	123 Fractyl Health GUTS $55.2M	–	–	–	–
124	124 Kyverna Therapeutics KYTX $369M	–	–	–	–
125	125 Lexeo Therapeutics LXEO $227M	–	–	–	–